The Hydration Pharmaceuticals Company Limited Stock
Stocks
HPC
AU0000187957
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.004000 AUD | 0.00% |
|
0.00% | -20.00% |
| Market Cap | 1.48M 1.29M 1.2M 1.1M 2.08M 141M 2.12M 14.16M 5.55M 70.36M 5.56M 5.44M 232M | P/E 2024 |
4.69x | P/E 2025 | -0.45x |
|---|---|---|---|---|---|
| Enterprise Value | 362K 314K 293K 269K 508K 34.47M 517K 3.46M 1.36M 17.19M 1.36M 1.33M 56.69M | EV / Sales 2024 |
0.06x | EV / Sales 2025 | 0.13x |
| Free-Float |
55.47% | Yield 2024 * |
-
| Yield 2025 | - |
| 6 months | -20.00% | ||
| Current year | -20.00% |
| 1 week | 0 | 0 | |
| 1 month | 0 | 0 | |
| Current year | 0 | 0.01 | |
| 1 year | 0 | 0.02 | |
| 3 years | 0 | 0.06 | |
| 5 years | 0 | 0.4 | |
| 10 years | 0 | 0.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Emily Lease
PRN | Corporate Officer/Principal | - | 2026-06-14 |
Victoria Nadalin
SEC | Corporate Secretary | - | 2023-02-07 |
| Director | Title | Age | Since |
|---|---|---|---|
Margaret Hardin
BRD | Director/Board Member | 53 | 2022-02-07 |
Nicholas Berry
CHM | Chairman | - | 2026-06-15 |
| Director/Board Member | - | 2026-06-15 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 10/4/23 | Free | Chairman | 500,000 | 0.2112% | ||
| 10/4/23 | Buy | Director | 333,333 | 0.1408% | ||
| 10/4/23 | Free | Director | 166,667 | 0.0704% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | 0.00% | -73.33% | -93.33% | 1.48M | ||
| -2.39% | -6.36% | +45.82% | +149.66% | 1,024B | ||
| -0.76% | -4.34% | +48.74% | +49.09% | 618B | ||
| -2.33% | -4.60% | +24.30% | +64.44% | 443B | ||
| +0.68% | +0.25% | +38.47% | +31.95% | 349B | ||
| -1.66% | -1.89% | +32.18% | +37.17% | 297B | ||
| -8.96% | -9.23% | +3.57% | +3.64% | 264B | ||
| -1.37% | -5.71% | -2.10% | -44.43% | 209B | ||
| -1.63% | +0.69% | +25.48% | +64.23% | 208B | ||
| +0.72% | +0.48% | +14.53% | +73.64% | 162B | ||
| Average | -1.86% | -1.21% | +15.76% | +33.61% | 357.38B | |
| Weighted average by Cap. | -1.93% | -2.17% | +33.29% | +70.34% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 3.2M 2.79M 2.6M 2.39M 4.5M 305M 4.58M 30.66M 12.01M 152M 12.04M 11.77M 502M | 2.47M 2.15M 2.01M 1.84M 3.47M 236M 3.53M 23.65M 9.26M 117M 9.28M 9.08M 388M |
| Net income | 2.67M 2.32M 2.16M 1.99M 3.75M 254M 3.81M 25.52M 10M 127M 10.02M 9.8M 418M | -2.86M -2.49M -2.32M -2.13M -4.02M -273M -4.09M -27.37M -10.72M -136M -10.75M -10.51M -449M |
| Net Debt | -3.22M -2.8M -2.61M -2.4M -4.52M -307M -4.6M -30.77M -12.05M -153M -12.08M -11.81M -504M | -1.12M -972K -908K -833K -1.57M -107M -1.6M -10.7M -4.19M -53.17M -4.2M -4.11M -175M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-03 | A$0.004000 | 0.00% | 15,000 |
| 26-07-31 | A$0.004000 | 0.00% | 300,000 |
| 26-07-29 | A$0.004000 | 0.00% | 32,470 |
- Stock Market
- Stocks
- HPC Stock
Select your edition
All financial news and data tailored to specific country editions
















